Ignite Creation Date:
2024-05-06 @ 7:24 AM
Last Modification Date:
2024-10-26 @ 11:48 AM
Study NCT ID:
NCT02525939
Status:
COMPLETED
Last Update Posted:
2022-10-12
First Post:
2015-08-13
Brief Title:
Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS
Sponsor:
DalCor Pharmaceuticals
Organization:
DalCor Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-13
First Submit QC Date:
August 14 2015
Study First Post Date:
2015-08-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-10-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-09
Last Update Post Date:
2022-10-12
Last Update Post Date Type:
ACTUAL